Penumbra
PEN
$208.55
Share price
1.21%
Change (1 day)
-30.72%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Operating Margin for Penumbra (PEN)
Operating Margin as of May 2024 (TTM): 3.85%
According to Penumbra's latest financial reports and stock price the company's current Operating Margin is 3.85%. At the end of 2022 the company had an Operating Margin of 0.46%.
Operating Margin history for Penumbra from 2015 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 0.46% | -132.7% |
| 2021 | -1.40% | -79.29% |
| 2020 | -6.78% | -174.07% |
| 2019 | 9.16% | 2434.23% |
| 2018 | 0.36% | -51.28% |
| 2017 | 0.74% | -324.79% |
| 2016 | -0.33% | -115.26% |
| 2015 | 2.16% | -13.54% |
| 2014 | 2.50% | -277.06% |
| 2013 | -1.41% | -126.55% |
| 2012 | 5.32% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 7.17% | 86.23% | 🇺🇸 USA |
 Inari Medical
NARI | -2.74% | -171.17% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.